Doximity (NYSE:DOCS) CAO Siddharth Sitaram Sells 2,613 Shares of Company Stock

Doximity, Inc. (NYSE:DOCS) CAO Siddharth Sitaram sold 2,613 shares of Doximity stock in a transaction on Wednesday, October 14th. The stock was sold at an average price of $30.68, for a total value of $80,166.84. Following the completion of the sale, the chief accounting officer directly owned 101,432 shares of the company’s stock, valued at $3,111,933.76. The trade was a 2.51% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Siddharth Sitaram also recently made the following trade(s):

• On Tuesday, September 15th, Siddharth Sitaram sold 2,077 shares of Doximity stock. The shares were sold at an average price of $26.02, for a total value of $54,043.54.
• On Thursday, August 13th, Siddharth Sitaram sold 1,770 shares of Doximity stock. The shares were sold at an average price of $24.94, for a total value of $44,143.80.

Doximity Trading Down 2.2%

DOCS stock traded down $0.69 during trading on Friday, reaching $30.81. The stock had a trading volume of 3,582,714 shares, compared to its average volume of 3,989,128. The firm has a market cap of $5.49 billion, a PE ratio of 36.25, a PEG ratio of 23.40 and a beta of 1.22. The stock’s 50 day moving average is $26.68 and its two-hundred day moving average is $23.58. Doximity, Inc. has a 52 week low of $17.15 and a 52 week high of $71.37.

Doximity (NYSE:DOCS) last released its quarterly earnings results on Thursday, August 6th. The company reported $0.29 earnings per share for the quarter, topping the consensus estimate of $0.16 by $0.13. The business had revenue of $156.62 million for the quarter. Doximity had a net margin of 25.48% and a return on equity of 18.06%. The firm’s revenue was up 7.3% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.36 earnings per share. On average, research analysts anticipate that Doximity, Inc. will post 0.74 EPS for the current year.

Analyst Ratings Changes

Several research firms recently issued reports on DOCS. Barclays increased their target price on Doximity from $20.00 to $27.00 and gave the stock an “equal weight” rating in a research report on Friday, August 21st. Evercore set a $35.00 price target on Doximity in a report on Tuesday, September 29th. Zacks Research upgraded Doximity from a “strong sell” rating to a “hold” rating in a research note on Monday, July 13th. JPMorgan Chase & Co. upped their price target on Doximity from $26.00 to $31.00 and gave the stock a “neutral” rating in a research note on Friday, August 7th. Finally, Stifel Nicolaus set a $27.00 price objective on shares of Doximity in a report on Tuesday, September 8th. Eight analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $30.73.

More Doximity News

Here are the key news stories impacting Doximity this week:

• Positive Sentiment: Doximity extended its 13-year alliance with U.S. News, supporting physician searches, appointment booking and hospital rankings. The partnership could reinforce user engagement and patient-access offerings. Doximity Deepens U.S. News Alliance to Improve Patient Access to Care
• Neutral Sentiment: Doximity will release fiscal 2027 second-quarter results on November 5, giving investors the next major opportunity to assess growth, advertising trends and management’s outlook. Doximity to Release Fiscal 2027 Second Quarter Results on November 5, 2026
• Negative Sentiment: Several law firms publicized a securities-fraud class action against Doximity and certain individuals, including co-founder and former Chief Strategy Officer Nate Gross. The allegations reportedly concern statements that Doximity could gain market share while older advertising formats were losing ground to programmatic and social-media competitors; the claims have not been established in court.
• Negative Sentiment: Investors who purchased DOCS shares between August 8, 2024 and May 13, 2026 are being reminded that November 16, 2026 is the deadline to seek appointment as lead plaintiff. Repeated announcements from Robbins Geller, SBS Law, Kaplan Fox, Rosen, Pomerantz, Bronstein Gewirtz Grossman and other firms increase the visibility of the legal overhang and could weigh on sentiment. DOCS Investor Alert

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in DOCS. Versant Capital Management Inc lifted its position in shares of Doximity by 1,176.9% in the third quarter. Versant Capital Management Inc now owns 1,826 shares of the company’s stock worth $52,000 after buying an additional 1,683 shares in the last quarter. Parallel Advisors LLC boosted its stake in Doximity by 111.0% during the first quarter. Parallel Advisors LLC now owns 2,560 shares of the company’s stock valued at $60,000 after buying an additional 1,347 shares during the last quarter. Fortitude Family Office LLC boosted its stake in Doximity by 31,271.4% during the third quarter. Fortitude Family Office LLC now owns 2,196 shares of the company’s stock valued at $62,000 after buying an additional 2,189 shares during the last quarter. EverSource Wealth Advisors LLC grew its holdings in Doximity by 937.7% during the 1st quarter. EverSource Wealth Advisors LLC now owns 2,833 shares of the company’s stock valued at $66,000 after buying an additional 2,560 shares in the last quarter. Finally, Continuum Advisory LLC purchased a new position in Doximity during the 2nd quarter valued at approximately $67,000. Hedge funds and other institutional investors own 87.19% of the company’s stock.

Doximity Company Profile

Doximity, Inc operates a digital platform designed for U.S. medical professionals. Its network enables physicians, nurse practitioners, physician assistants and other healthcare providers to connect with colleagues, exchange clinical information and access professional resources.

The company offers tools for telehealth and care coordination, including video and phone-based communication services, as well as digital faxing and secure messaging capabilities. Doximity also provides medical news and research content tailored to healthcare professionals.

Doximity generates additional business through recruiting and marketing solutions that help healthcare organizations reach clinicians and promote employment opportunities, services and products.